In summary, this book provides a readable introduction and overview of the changing, yet to be settled, intellectual property landscape in plant biotechnology. One hopes that the book will be on ...

Williams previously served as CEO and co-founder of ImmusanT, another Arch Venture Partners-backed biotech. The company stopped a phase 2 trial of its celiac disease program in June 2019 after an ...